Company Quick10K Filing
Pulmonx Corp
10-Q 2020-09-30 Filed 2020-11-13
S-1 2020-09-04 Public Filing
10-Q 2020-06-30 Filed 2020-09-16
10-Q 2020-03-31 Filed 2020-08-25
S-1 2020-02-28 Public Filing
10-K 2019-12-31 Filed 2020-07-15
10-Q 2019-09-30 Filed 2020-05-08
10-Q 2019-06-30 Filed 2020-03-04
10-Q 2019-03-31 Filed 2019-06-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-15
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-04-03
10-Q 2013-09-30 Filed 2013-12-09
10-Q 2013-03-31 Filed 2013-10-17
10-Q 2013-03-31 Filed 2013-10-17
10-K 2012-12-31 Filed 2013-08-30
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-17
10-Q 2012-03-31 Filed 2012-05-21
8-K 2020-05-27
8-K 2020-05-22
8-K 2020-03-09
8-K 2020-02-27
8-K 2020-02-13
8-K 2020-02-12
8-K 2019-11-27
8-K 2019-11-26
8-K 2019-08-07
8-K 2019-08-07
8-K 2019-08-02
8-K 2019-06-10
8-K 2018-12-03
8-K 2018-11-01
8-K 2018-10-25
8-K 2018-10-23
8-K 2018-10-02
8-K 2018-10-01
8-K 2018-09-19
8-K 2018-09-13
8-K 2018-09-05
8-K 2018-08-27
8-K 2018-08-15
8-K 2018-07-30
8-K 2018-07-10
8-K 2018-06-26
8-K 2018-02-22

Pulmonx Corp Financials

LUNG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2013-03-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash65187476921449171,3019764522045412,9551,7836372,1021,41372124936
Accounts Receivable20517115513712856000
Inventory12115217233210223213209353535350000000
PP&E1187477474741268515073615414340
Assets186435904894741,3691,7631,3681,0067956566963,6782,6931,4652,9391,9231,199467243
Accounts Payable2296384146107106105896999989919732878195296440232217264247
Long-Term Debt1801551559090001,2071,3081,2071,2072,9593,2703,4033,5374,324
Liabilities2,4722,4011,8811,8921,8802,0471,8882,9913,5453,6293,6583,5063,5583,4341,4641,4671,5283,4763,6133,8004,0444,911
Stockholders' Equity-2,453-2,342-1,776-1,248-1,290-1,558-1,414-1,622-1,782-2,261-2,652-2,711-2,902-2,7392,2141,227-63-537-1,690-2,649-3,577-4,668
Income Statement ($'000)2013-03-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue0215117144100000000000
Cost of Revenue26231448010000000000
Gross Profit1899401130-10000000000
R&D171872819016915695134354390373304260242519274596426837413197
SG&A181324-3982206153362192172213984214222843601,0641,0681,1431,084613362209
Tax000000000
Net Income-248-393-464-452-637-457-377-420-602-867-874-808-611-668-1,278-1,366-1,763-1,556-1,799-992-1,138
Cash Flow ($'000)2013-03-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating-151-396-265-460-484-187-210-320-795-588-853-686-371-398-1,008-1,211-1,053-840-692-363
Cash Investing0-21-360-270-44-10200-8-7090
Cash Financing1544423008851001362001,2331,198308430438172433-155712,5181430150